Article Text
PDF
Statistics from Altmetric.com
OpenUrlCrossRefPubMedWeb of Science
Q Is divalproex more cost effective than lithium for adults with bipolar disorder?
METHODS
Design:
Randomised controlled trial.
Allocation:
Not clear.
Blinding:
Unblinded.
Follow up period:
Twelve months.
Setting:
Thirty three university and community based psychiatric practices, USA; 1995–97.
Patients:
221 people 18 years or over with bipolar disorder (DSM-IV) hospitalised for an acute manic or mixed episode. Exclusions: serious neurological abnormalities; seizure disorders; drug or AIDS induced mania; uncontrolled medical comorbidity; taking anticoagulants; breastfeeding or likely to become pregnant.
Intervention:
Divalproex sodium (15–20 mg/kg/day) or lithium (up to 1800 mg/day in the acute treatment phase; 900–1200 mg/day in the maintenance phase). All participants also received usual psychiatric care.
Outcomes:
Quality of life (QOL; …
Footnotes
For correspondence: D A Revicki, Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA; revicki{at}medtap.com
Sources of funding: Abbott Laboratories, Abbott Park, Illinois, USA
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.